News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
253,347 Results
Type
Article (36816)
Company Profile (19)
Press Release (216512)
Section
Business (71247)
Career Advice (453)
Deals (7071)
Drug Delivery (12)
Drug Development (32124)
Employer Resources (39)
FDA (6495)
Job Trends (5075)
News (115987)
Policy (8524)
Tag
Academia (2596)
Alliances (17122)
Alzheimer's disease (537)
Approvals (6468)
Artificial intelligence (38)
Bankruptcy (40)
Best Places to Work (4363)
Breast cancer (42)
Cancer (340)
Cardiovascular disease (45)
Career advice (417)
Cell therapy (66)
Clinical research (24683)
Collaboration (105)
COVID-19 (1794)
C-suite (59)
Cystic fibrosis (23)
Data (406)
Diabetes (42)
Diagnostics (2636)
Earnings (14052)
Employer resources (36)
Events (26017)
Executive appointments (186)
FDA (6650)
Funding (100)
Gene therapy (50)
GLP-1 (150)
Government (1806)
Healthcare (8972)
Infectious disease (1829)
Inflammatory bowel disease (39)
Interviews (45)
IPO (2982)
Job creations (807)
Job search strategy (392)
Layoffs (51)
Legal (1330)
Liver cancer (25)
Lung cancer (50)
Manufacturing (27)
Medical device (5967)
Medtech (5968)
Mergers & acquisitions (4106)
Metabolic disorders (102)
Neuroscience (610)
NextGen Class of 2024 (3040)
Non-profit (2539)
Northern California (436)
Obesity (50)
Opinion (38)
People (34573)
Phase I (7357)
Phase II (11043)
Phase III (8193)
Pipeline (86)
Postmarket research (1363)
Preclinical (3456)
Press Release (26)
Radiopharmaceuticals (84)
Rare diseases (56)
Real estate (1839)
Regulatory (5842)
Research institute (1653)
Resumes & cover letters (33)
Southern California (323)
Startups (1418)
United States (3693)
Vaccines (299)
Weight loss (24)
Date
Today (56)
Last 7 days (234)
Last 30 days (975)
Last 365 days (11068)
2024 (9513)
2023 (13358)
2022 (20673)
2021 (22363)
2020 (22043)
2019 (19069)
2018 (14230)
2017 (12359)
2016 (12417)
2015 (14176)
2014 (10728)
2013 (10163)
2012 (10391)
2011 (10646)
2010 (9544)
Location
Africa (342)
Arizona (61)
Asia (15293)
Australia (3232)
California (845)
Canada (335)
China (74)
Colorado (56)
Connecticut (41)
Europe (36068)
Florida (138)
Georgia (34)
Illinois (142)
Indiana (55)
Kansas (23)
Maryland (134)
Massachusetts (549)
Michigan (23)
Minnesota (74)
New Jersey (288)
New York (262)
North Carolina (310)
Northern California (436)
Ohio (56)
Pennsylvania (213)
South America (443)
Southern California (323)
Texas (129)
Utah (26)
Washington State (93)
253,347 Results for "georgetown university hospital".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioCapital
KeifeRx Expands Exclusive Licensing Agreement with Georgetown University to Include Multiple Disease Indications for Portfolio of Novel Tyrosine Kinase Inhibitors
KeifeRx announced entry into an amended exclusive licensing agreement with Georgetown University to advance the development of novel tyrosine kinase inhibitor chemical entities for the treatment of multiple disease indications.
January 8, 2024
·
3 min read
BioMidwest
Cantex Pharmaceuticals Obtains Exclusive Worldwide Rights to Intellectual Property From Georgetown University for Azeliragon as a Potential Treatment of Cancer-Related Cognitive Decline
Cantex Pharmaceuticals, Inc. announced that it has obtained an exclusive worldwide license from Georgetown University for intellectual property related to the potential use of azeliragon to treat, prevent or alleviate cancer-treatment related cognitive decline.
June 1, 2023
·
4 min read
Bio NC
vTv Therapeutics Partner Cantex Pharmaceuticals Licenses Exclusive Rights to Intellectual Property from Georgetown University for Azeliragon as a Potential Treatment for Cancer-Related Cognitive Decline
vTv Therapeutics Inc. announced that Cantex Pharmaceuticals, Inc. recently obtained an exclusive worldwide license from Georgetown University for intellectual property related to the potential use of azeliragon to treat, prevent or alleviate cancer treatment-related cognitive decline.
June 16, 2023
·
5 min read
BioMidwest
Heidelberg University Hospital in Germany Invests in Fourth Accuray Radiotherapy Device, the Radixact® System, to Improve Cancer Patient Care
Accuray Incorporated announced that long-term customer Heidelberg University Hospital in Heidelberg, Germany, has selected the company’s Radixact® System, equipped with its proprietary ClearRT®, Synchrony® and VOLO™ Ultra Optimizer solutions, to help transform their approach to cancer care.
June 27, 2024
·
5 min read
Bio NC
Asensus Surgical Announces St. Marianna University School of Medicine Yokohama City Seibu Hospital in Japan to Initiate Senhance Surgery Program
Asensus Surgical, Inc. announced that St. Marianna University School of Medicine Yokohama City Seibu Hospital in Japan has entered into an agreement to lease and utilize a Senhance® Surgical System in the Urology and Gastroenterology/General Surgery department.
June 24, 2024
·
5 min read
Business
Evotec, Inserm, Lille University Hospital and Inserm Transfert Enter Collaboration to Identify Novel Therapeutic Targets in Obesity and Metabolic Diseases
Evotec SE announced that the Company entered a partnership with Inserm, the French National Institute of Health and Medical Research, Lille University Hospital and Inserm Transfert to identify novel therapeutic targets and diagnostic and prognostic markers in obesity and metabolic diseases.
May 30, 2024
·
11 min read
Drug Development
OSE Immunotherapeutics and Nantes University Hospital Present Positive Phase 1/2 Study Evaluating FR104/VEL-101 Immunotherapy in Renal Transplant
OSE Immunotherapeutics SA and Nantes University Hospital present positive Phase 1/2 analysis from first use of anti-CD28 FR104/VEL-101 in kidney transplantation in oral presentation at the Annual American Transplant Congress held in Philadelphia.
June 5, 2024
·
11 min read
BioCapital
Shuttle Pharmaceuticals Enters Research Agreement with Georgetown University for Testing of Small Molecule Radiation Sensitizers and Immune Activation Candidates
Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) today announced it has entered a research agreement with Georgetown University focused on the evaluation of the Company’s lead HDAC6 inhibitor candidate, SP-2-225, evaluating the anti-tumor effect of the combination of SP-2-225 and RT in a syngeneic breast cancer model.
March 22, 2023
·
4 min read
Press Releases
ENDRA Life Sciences Activates TAEUS System to Initiate Clinical Study at LMU University Hospital in Germany
October 23, 2024
·
5 min read
BioMidwest
Masimo and Cleveland Clinic Collaborate to Improve Hospital Remote Care
Masimo, a leading global provider of medical technology and hospital automation solutions, and Cleveland Clinic, a nonprofit academic medical center, announced the launch of a new partnership centered around hospital-based remote patient monitoring, including TeleCritical Care.
June 27, 2024
·
10 min read
1 of 25,335
Next
